HRP20110076T1 - Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol - Google Patents

Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol Download PDF

Info

Publication number
HRP20110076T1
HRP20110076T1 HR20110076T HRP20110076T HRP20110076T1 HR P20110076 T1 HRP20110076 T1 HR P20110076T1 HR 20110076 T HR20110076 T HR 20110076T HR P20110076 T HRP20110076 T HR P20110076T HR P20110076 T1 HRP20110076 T1 HR P20110076T1
Authority
HR
Croatia
Prior art keywords
pain
dimethylamino
phenol
propyl
ethyl
Prior art date
Application number
HR20110076T
Other languages
English (en)
Croatian (hr)
Inventor
Bloms-Funke Petra
Schiene Klaus
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110076(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of HRP20110076T1 publication Critical patent/HRP20110076T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20110076T 2006-04-28 2007-04-25 Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol HRP20110076T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008851 2006-04-28
PCT/EP2007/003632 WO2007128413A1 (en) 2006-04-28 2007-04-25 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (1)

Publication Number Publication Date
HRP20110076T1 true HRP20110076T1 (hr) 2011-02-28

Family

ID=37025148

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110076T HRP20110076T1 (hr) 2006-04-28 2007-04-25 Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol

Country Status (24)

Country Link
EP (1) EP2012764B1 (de)
JP (2) JP5496653B2 (de)
KR (1) KR101396166B1 (de)
CN (1) CN101431990B (de)
AT (1) ATE494889T1 (de)
AU (1) AU2007247481B2 (de)
BR (1) BRPI0710682B8 (de)
CA (1) CA2650423C (de)
CY (1) CY1111369T1 (de)
DE (1) DE602007011913D1 (de)
DK (1) DK2012764T3 (de)
EC (2) ECSP088793A (de)
ES (1) ES2356093T3 (de)
HR (1) HRP20110076T1 (de)
IL (1) IL194883A (de)
MX (1) MX2008013779A (de)
NO (2) NO341602B1 (de)
NZ (1) NZ571442A (de)
PL (1) PL2012764T3 (de)
PT (1) PT2012764E (de)
RU (1) RU2442576C2 (de)
SI (1) SI2012764T1 (de)
WO (1) WO2007128413A1 (de)
ZA (1) ZA200810124B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012165A1 (de) * 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
CN102908339A (zh) * 2007-11-23 2013-02-06 格吕伦塔尔有限公司 他喷他多组合物
SI2582366T1 (sl) 2010-06-15 2016-02-29 Gruenenthal Gmbh Farmacevtska kombinacija za zdravljenje bolečine
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
EP2808319A1 (de) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(dimethylamin)-1-ethyl-2-methylpropyl]phenolharzkomplex
EP3273953B1 (de) 2015-03-27 2019-01-02 Grünenthal GmbH Stabile formulierung zur parenteralen verabreichung von tapentadol
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
WO2018153947A1 (en) 2017-02-23 2018-08-30 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
PT1562567T (pt) * 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii

Also Published As

Publication number Publication date
RU2008146816A (ru) 2010-06-10
IL194883A0 (en) 2009-08-03
PT2012764E (pt) 2011-02-02
SI2012764T1 (sl) 2011-03-31
DK2012764T3 (da) 2011-02-28
CA2650423C (en) 2014-08-12
CA2650423A1 (en) 2007-11-15
JP2013213045A (ja) 2013-10-17
AU2007247481B2 (en) 2013-02-14
EP2012764B1 (de) 2011-01-12
NO20171831A1 (no) 2008-10-28
RU2442576C2 (ru) 2012-02-20
JP5496653B2 (ja) 2014-05-21
ECSP17000643A (es) 2018-06-30
JP2009535313A (ja) 2009-10-01
CY1111369T1 (el) 2015-08-05
WO2007128413A1 (en) 2007-11-15
BRPI0710682A2 (pt) 2011-08-23
ATE494889T1 (de) 2011-01-15
NO20084542L (no) 2008-10-28
ECSP088793A (es) 2008-11-27
IL194883A (en) 2012-10-31
BRPI0710682B1 (pt) 2020-09-24
EP2012764A1 (de) 2009-01-14
PL2012764T3 (pl) 2011-04-29
KR20090006219A (ko) 2009-01-14
ES2356093T3 (es) 2011-04-04
HK1127289A1 (en) 2009-09-25
NO341602B1 (no) 2017-12-11
NO343505B1 (no) 2019-03-25
CN101431990A (zh) 2009-05-13
ZA200810124B (en) 2009-08-26
CN101431990B (zh) 2011-08-03
DE602007011913D1 (de) 2011-02-24
NZ571442A (en) 2011-09-30
KR101396166B1 (ko) 2014-05-27
BRPI0710682B8 (pt) 2021-05-25
AU2007247481A1 (en) 2007-11-15
MX2008013779A (es) 2008-11-14

Similar Documents

Publication Publication Date Title
HRP20110076T1 (hr) Farmaceutske kombinacije koje sadrže 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i paracetamol
HRP20190500T1 (hr) Farmaceutska kombinacija 3-(3-dimetilamino-1-etil-2-metil-propil)-fenola i pregabalina ili gabapentina
HRP20110271T1 (hr) Farmaceutska kombinacija koja sadrži 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol i nsaid (nesteroidni antiinflamatorni lijek)
HRP20151327T1 (hr) Farmaceutska kombinacija za lijeäśenje boli
CA2653569C (en) S1p receptor modulators for treating multiple sclerosis
HRP20120866T1 (hr) Makrocikliäśni spojevi hinoksalina kao inhibitori hcv ns3 proteaze
JP2007533686A5 (de)
ES3055488T3 (en) Tegavivint for use in the treatment of pulmonary fibrosis
HRP20211032T1 (hr) Postupci za uporabu agonista fxr
RU2013121788A (ru) Ингибиторы репликации вич
JP2009504763A5 (de)
EP2275107A3 (de) Kombinationen zur Behandlung von Erkrankungen im Zusammenhang mit Zellproliferation
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
ES3029560T3 (en) 5-amino-2,3-dihydro-1,4-phthalazinedione as glucocorticoid-sparing agent
CO6220902A2 (es) Formulacion en polvo del valganciclovir
HRP20140215T1 (hr) Kombinacija koja sadrži paklitaksel za lijeäśenje raka jajnika
RU2349323C2 (ru) Комбинация избирательного ингибитора обратного захвата норадреналина и ингибитора pdev
JP2020533402A5 (de)
JP2009520010A5 (de)
MX2024002892A (es) Azalidos inmunomoduladores.
JP2009538822A (ja) 静脈におけるウイルスの治療
JP2009533428A (ja) 筋肉内抗ウイルス処置
RU2016115376A (ru) Фармацевтические композиции, содержащие антибактериальные агенты
RU2010151433A (ru) Терапевтическое средство против боли
HRP20110225T1 (hr) Nova kombinacija lijekova kao antidepresivi